Putnam Investments LLC Axsome Therapeutics, Inc. Call Options Transaction History
Putnam Investments LLC
- $73 Billion
- Q4 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AXSM
# of Institutions
308Shares Held
40.3MCall Options Held
429KPut Options Held
615K-
Rtw Investments, LP New York, NY4.63MShares$461 Million6.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$397 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$328 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$235 Million37.71% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.85MShares$184 Million4.89% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.27B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...